Efficacy and cost effectiveness of current therapies in Guillain Barre syndrome.
Mehndiratta
M M
MM
Department of Neurology, GB Pant Hospital, New Delhi.
Chowdhury
D
D
Goel
V
V
D000305:Adrenal Cortex Hormones / Q000008:administration & dosage*; D000328:Adult; D000368:Aged; D002675:Child, Preschool; D003131:Combined Modality Therapy; D003362:Cost-Benefit Analysis; D005260:Female; D020275:Guillain-Barre Syndrome / Q000175:diagnosis / Q000191:economics* / Q000628:therapy*; D017048:Health Care Costs; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000008:administration & dosage*; D007194:India; D008297:Male; D008875:Middle Aged; D010951:Plasma Exchange / Q000191:economics* / Q000379:methods; D010956:Plasmapheresis / Q000191:economics* / Q000379:methods; D011247:Pregnancy; D011379:Prognosis; D012720:Severity of Illness Index; D016896:Treatment Outcome
D000305:Adrenal Cortex Hormones; D016756:Immunoglobulins, Intravenous